Breast cancer: a molecularly heterogenous disease needing subtype-specific treatments

U Testa, G Castelli, E Pelosi - Medical Sciences, 2020 - mdpi.com
Breast cancer is the most commonly occurring cancer in women. There were over two-
million new cases in world in 2018. It is the second leading cause of death from cancer in …

Breast cancer in the era of precision medicine

N Sarhangi, S Hajjari, SF Heydari, M Ganjizadeh… - Molecular Biology …, 2022 - Springer
Breast cancer is a heterogeneous disorder with different molecular subtypes and biological
characteristics for which there are diverse therapeutic approaches and clinical outcomes …

Breast cancer: an up‐to‐date review and future perspectives

R Hong, B Xu - Cancer communications, 2022 - Wiley Online Library
Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Extensive review on breast cancer its etiology, progression, prognostic markers, and treatment

H Swaminathan, K Saravanamurali, SA Yadav - Medical Oncology, 2023 - Springer
As the most frequent and vulnerable malignancy among women, breast cancer universally
manifests a formidable healthcare challenge. From a biological and molecular perspective, it …

[HTML][HTML] Clinical and molecular aspects of breast cancer: Targets and therapies

RLN Godone, GM Leitão, NB Araújo… - Biomedicine & …, 2018 - Elsevier
Breast Cancer is a complex disease characterized by the occurrence of multiple molecular
alterations. Currently, some molecular markers are in use for breast cancer diagnostic …

Breast cancer

N Harbeck, F Penault-Llorca… - Nature reviews …, 2019 - mayoclinic.elsevierpure.com
Breast cancer is the most frequent malignancy in women worldwide and is curable in~ 70–
80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with …

Personalized therapy for breast cancer

FB De Abreu, GN Schwartz, WA Wells… - Clinical …, 2014 - Wiley Online Library
Breast cancer is a complex disease characterized by many morphological, clinical and
molecular features. For many years, this disease has been classified according to …

The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

FJ Velloso, AFR Bianco, JO Farias… - OncoTargets and …, 2017 - Taylor & Francis
Cancer is the disease with highest public health impact in developed countries. Particularly,
breast cancer has the highest incidence in women worldwide and the fifth highest mortality …

Targeted therapies in breast cancer: where are we now?

S Di Cosimo, J Baselga - European Journal of Cancer, 2008 - Elsevier
Over the past several years significant advances have been made in our understanding of a
growing number of critical pathways involved in breast cancer. These advances have led to …

Histological and molecular classification of breast cancer: what do we know?

RG do Nascimento, KM Otoni - Mastology, 2020 - revistamastology.emnuvens.com.br
Breast cancer is the neoplasm most diagnosed malignancy and the leading cause of
mortality among women on a global scale. A profound increase in the understanding and …